Effectiveness and safety of rituximab in autoimmune nodopathy: a single-center cohort study.

MLA

Liu, Bingyou, et al. “Effectiveness and Safety of Rituximab in Autoimmune Nodopathy: A Single-Center Cohort Study.” Journal of Neurology, vol. 270, no. 9, Sept. 2023, pp. 4288–95. EBSCOhost, https://doi.org/10.1007/s00415-023-11759-2.

APA

Liu, B., Hu, J., Sun, C., Qiao, K., Xi, J., Zheng, Y., Sun, J., Luo, S., Zhao, Y., Lu, J., Lin, J., & Zhao, C. (2023). Effectiveness and safety of rituximab in autoimmune nodopathy: a single-center cohort study. Journal of Neurology, 270(9), 4288–4295. https://doi.org/10.1007/s00415-023-11759-2

Chicago

Liu, Bingyou, Jianian Hu, Chong Sun, Kai Qiao, Jianying Xi, Yongsheng Zheng, Jian Sun, et al. 2023. “Effectiveness and Safety of Rituximab in Autoimmune Nodopathy: A Single-Center Cohort Study.” Journal of Neurology 270 (9): 4288–95. doi:10.1007/s00415-023-11759-2.